Novo Nordisk acquires Bristol based biopharmaceutical start-upAllbiopro2018-08-21T02:05:37+09:008월 21st, 2018|
Novo Nordisk Acquires Ziylo in Possible $800 Million-Plus DealAllbiopro2018-08-18T12:15:18+09:008월 18th, 2018|
August 17 Research Roundup: Glaucoma, Lung Cancer, Migraines and SpaghettiAllbiopro2018-08-18T12:14:51+09:008월 18th, 2018|
Bristol-Myers Squibb’s Opdivo secures a lung cancer niche with small-cell green lightAllbiopro2018-08-18T12:13:57+09:008월 18th, 2018|
Days after FDA rejection, Regeneron wins label expansion for EyleaAllbiopro2018-08-18T12:13:29+09:008월 18th, 2018|
Eisai, Merck take on Bayer’s Nexavar with new liver cancer nod for LenvimaAllbiopro2018-08-18T12:13:01+09:008월 18th, 2018|
Bristol-Myers Squibb’s Opdivo Gets New Approval for Lung Cancer IndicationAllbiopro2018-08-18T12:12:34+09:008월 18th, 2018|
Novo buys Ziylo for glucose-responsive insulin platformAllbiopro2018-08-18T12:12:06+09:008월 18th, 2018|
Sirnaomics cleared to start first trial of RNAi lead in cancerAllbiopro2018-08-18T12:11:12+09:008월 18th, 2018|
AbbVie, Tolero team up to test Venclexta combo in AMLAllbiopro2018-08-18T12:10:45+09:008월 18th, 2018|
Chutes & Ladders—Gilead CMO to quit 6 months after taking the jobAllbiopro2018-08-18T12:10:19+09:008월 18th, 2018|
Ex-Shire director to aid Catalent’s shift to commercial manufacturingAllbiopro2018-08-18T12:09:23+09:008월 18th, 2018|
Light-engineered bacterial shapes could hold key to future labs-on-a-chipAllbiopro2018-08-18T12:08:05+09:008월 18th, 2018|
